BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


DSM Biologics 

6000, Royalmount Avenue

Montreal  Quebec  H4P 2T1  Canada
Phone: 514-341-9940 Fax: 514-341-7821


View Clinical Trials from BioPharm Insight

DSM Biologics, a business unit of DSM Pharmaceutical Products, is a leading provider of manufacturing technology & services to the biopharmaceutical industry. In addition to offering world-class biopharmaceutical manufacturing services, DSM Biologics has co-exclusive rights, along with Dutch biotech company Crucell N.V., to license the high-producing PER.C6® human cell line as a production platform for recombinant proteins and monoclonal antibodies. DSM Biologics' FDA-approved facility in Groningen, the Netherlands was established in 1986, and has a strong track record in using a broad range of cell lines (PER.C6®, CHO, hybridoma, etc.) in biopharmaceutical manufacturing, and has wide-range of experience using multiple manufacturing (batch, fed-batch and continuous perfusion) and purification techniques. The combination of the PER.C6 human cell line and DSM's manufacturing services provides companies with a turn-key biologic manufacturing solution reducing cost, risk and time to market.

For more information, please visit

U.S. Headquarters:

DSM Pharmaceutical Products
45 Waterview Blvd.
Parsippany, N.J. 07054-1298
Phone: 973-257-8011

Last Updated: 03-27-2006

 Key Statistics

Ownership: Private

Web Site: DSM Biologics

 Company News
DSM Biologics Expands its Innovative Biomanufacturing Technology Portfolio With the Introduction of the New Kremer Method™ 6/28/2011 7:41:47 AM
DSM Biologics Reports a New Record Achievement with DSM's Proprietary XD(R) Process Technology with a CHO Cell Line Producing an Fc-fusion Protein: 2/9/2011 7:49:53 AM
DSM Biologics and NKT Therapeutics Inc. Sign Contract for Lead Product Development and Manufacture 2/8/2011 8:05:42 AM
DSM Biologics Announces Milestone Advancement of Yield-Boosting XD(R) Technology for Biomanufacturing 5/5/2010 11:52:43 AM
DSM Biologics to Acquire Rhobust(TM) Technology from Upfront Chromatography 5/5/2010 8:54:10 AM
DSM Biologics Announces Entering an Agreement with the Australian Governments to Build and Operate a Biopharmaceutical Manufacturing Facility in Brisbane 5/3/2010 10:09:43 AM
DSM PTG Unveils Bionate(R) II PCU 10/21/2009 9:00:22 AM
DSM Biologics Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms 5/18/2009 10:41:32 AM
DSM Biologics And Crucell N.V. (CRXL)l Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins 2/10/2009 12:07:30 PM
DSM Biologics and Crucell N.V. (CRXL) Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins 2/10/2009 9:10:15 AM